Getting a microbiome product to market requires a high level of understanding of how the taxa impact health. BioRankings® brings advanced biostatistical thinking, approaches, and software to your microbiome data analysis of the end product of your bioinformatics data processing pipeline. By adding biostatistics to your bioinformatics, BioRankings provides you with accurate, reproducible experimental design, sample size calculations, hypothesis testing, and other formal statistical analyses.
LEARN MORE >
Investing in pharmaceuticals or biotechnology can be risky because of the unpredictability of clinical trial outcomes. In addition to the rigorous due diligence you do with the company IP and financial data, looking closely into the scientific data can reduce investment risk. BioRankings® works with your investment team to dig into available data sources and determine if the clinical trial(s) you are basing your investment decision on are statistically correct and the likelihood they will reach statistical significance. LEARN MORE >
Current approaches for analyzing fMRI brain image connectomes use ‘off-the-shelf’ statistical methods not optimized for this type of data. This can often lead to spurious results and suboptimal analyses. BioRankings® collaborates with R&D teams to determine the best way to analyze your specific fMRI data, developing new analytical methods and software as needed. Working with BioRankings gives you fresh insight into your data, while improving your biomarker discovery pipeline and identifying possible drug targets for clinical treatment.
LEARN MORE >
Collaborate with the experts in complex data analysis. Your data is a valuable resource, and working with a partner in statistical analytics will ensure it can provide you not only the knowledge you need, but also avoid the risk of incorrectly analyzing your data producing results that are incorrect and might lead you to waste a lot of money on future R&D chasing what you believe are correct conclusions. BioRankings® works collaboratively with companies at all stages in their pipeline, from strategic planning, to study design, statistical computing, preparation for investor pitches, FDA applications, and publication submissions.
For more information on BioRankings® please contact us directly at:
We look forward to hearing from you.